Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Net Debt / EBITDA

Alexion Pharm Inc Net Debt / EBITDA Chart (ALXN)

Alexion Pharm Inc annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Alexion Pharm Inc Net Debt / EBITDA for the quarter ending June 06, 2020 was $0m a 2,460.72% decrease of 0m year over year
  • Alexion Pharm Inc Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a 2,470.80% decrease of 0m year over year
  • Alexion Pharm Inc Annual Net Debt / EBITDA for 2019 was $0m a -2,672.39% decrease of -1m from 2018
  • Alexion Pharm Inc Annual Net Debt / EBITDA for 2018 was $1m a -47.29% decrease of 0m from 2017
  • Alexion Pharm Inc Annual Net Debt / EBITDA for 2017 was $1m a -41.47% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN Net Debt / EBITDA Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m
03/2018$1m

Annual ALXN Net Debt / EBITDA Data

2019$0m
2018$1m
2017$1m
2016$2m
2015$3m
2014$-2m
2013$-2m
2012$-2m
2011$-2m
2010$-2m